| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lite Strategy, Inc. | Director | Common Stock | 100,000 | $139,570 | $1.40 | 19 Dec 2025 | Direct |
| SYNLOGIC, INC. | Director | Common Stock | 15,000 | $19,350 | $1.29 | 26 Apr 2025 | Direct |
| Lite Strategy, Inc. | Director | Stock Option (Right to Buy) | 55,000 | 14 Nov 2025 | Direct | ||
| ARCA biopharma, Inc. | Director | Stock Option (right to buy) | 6,000 | 30 Jan 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MEIP | Lite Strategy, Inc. | 19 Dec 2025 | 1 | +$97,699 | 4 | Director | 22 Dec 2025, 16:00 |
| MEIP | Lite Strategy, Inc. | 19 Nov 2025 | 1 | +$22,777 | 4 | Director | 20 Nov 2025, 16:00 |
| MEIP | Lite Strategy, Inc. | 14 Nov 2025 | 1 | $0 | 4 | Director | 18 Nov 2025, 17:08 |
| MEIP | Lite Strategy, Inc. | 01 Oct 2025 | 1 | +$25,430 | 4 | Director | 02 Oct 2025, 16:00 |
| MEIP | MEI Pharma, Inc. | 15 Jul 2025 | 1 | $0 | 4 | Director | 17 Jul 2025, 21:36 |
| SYBX | SYNLOGIC, INC. | 26 Apr 2025 | 1 | $0 | 4 | Director | 29 Apr 2025, 16:43 |
| MEIP | MEI Pharma, Inc. | 16 May 2024 | 1 | +$24,981 | 4 | Director | 20 May 2024, 16:00 |
| SYBX | SYNLOGIC, INC. | 19 Mar 2024 | 1 | $0 | 4 | Director | 21 Mar 2024, 17:09 |
| SYBX | SYNLOGIC, INC. | 19 Mar 2024 | 0 | $0 | 3 | Director | 21 Mar 2024, 17:06 |
| ORKA | ARCA biopharma, Inc. | 30 Jan 2024 | 1 | $0 | 4 | Director | 31 Jan 2024, 16:25 |
| /report/000157473624000003-flynn-james-p-2024-01-03 | RiceBran Technologies | 03 Jan 2024 | 0 | $0 | 3 | Director | 11 Jan 2024, 10:54 |
| MEIP | MEI Pharma, Inc. | 18 Dec 2023 | 2 | $0 | 4/A | Director | 12 Jan 2024, 16:00 |
| MEIP | MEI Pharma, Inc. | 18 Dec 2023 | 2 | $0 | 4 | Director | 20 Dec 2023, 21:25 |
| MEIP | MEI Pharma, Inc. | 31 Oct 2023 | 0 | $0 | 3 | Director | 03 Nov 2023, 18:04 |
| ORKA | ARCA biopharma, Inc. | 15 Dec 2022 | 1 | $0 | 4 | Director | 19 Dec 2022, 15:19 |
| ORKA | ARCA biopharma, Inc. | 15 Dec 2022 | 0 | $0 | 3 | Director | 19 Dec 2022, 15:17 |